Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
Article in Biomedicines (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Assessment of the excitation–inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamics
Article in Cerebral Cortex (May 2024)
A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders
Article in Frontiers in Psychiatry (January 2024)